Urologic Oncology
Karim Chamie, MD
Director of the Institute of Urologic Oncology Fellowship and Bladder Cancer Programs, Dr. Chamie is an Associate Professor of Urology and Society of Urologic Oncology Fellowship Director. He attended Medical School at the University of Southern California (USC) and completed Urological training at UC Davis. More >
Arnold I. Chin, MD, PhD
Associate Professor of Urology and Medical Director, Urology-Westwood, Dr. Chin completed his M.D., Ph.D. and Urology residency training at UCLA. His clinical expertise includes urologic oncology and renal transplantation, performing open, laparoscopic, and robotic-assisted surgeries for patients with all urologic malignancies including bladder, kidney, and prostate cancer. More >
Nicholas M. Donin, MD
Assistant Clinical Professor of Urology. After graduating from Harvard University, he received his medical degree from Columbia University in New York City and completed his internship and residency at New York University. He then completed a 2-year Urologic Oncology Fellowship at UCLA David Geffen School of Medicine. More >
Stuart Holden, MD
Health Sciences Clinical Professor of Urology and Co-Director, UCLA Institute of Urologic Oncology. Dr. Holden is recognized as an expert in prostate cancer research throughout the medical community. His dedication to patient care led to him being named medical director of the Prostate Cancer Foundation. More >
Mark S. Litwin, MD
Chair, Department of Urology. Professor of Urology, Health Policy & Management, and Nursing, Dr. Litwin trained at Harvard and specializes in testicular, bladder, prostate and kidney cancer. Dr. Litwin’s research focuses on improving quality of care, quality of life, and equitable access to care in urologic oncology. More >
Leonard S. Marks, MD
Professor of Urology. He completed training at UCLA in 1978. He received an American Foundation for Urologic Diseases scholarship award and a Prostate Cancer Foundation research award. His current research interests involve prostate markers, imaging, and minimally-invasive treatments, and clinical interests include active surveillance, HIFU and targeted biopsy for prostate cancer. More >
Allan J. Pantuck, MD
Professor of Urology and head of the UCLA IUO Clinical Research Program. Dr. Pantuck specializes in urologic cancers and has a long-standing interest in kidney, prostate, bladder cancers, developing new treatment strategies through basic and clinical research and in the study of nutritional approaches to their prevention and treatment. More >
Aydin Pooli, MD
Clinical Instructor of Urology. Dr. Pooli earned his medical degree from Tehran University of Medical Sciences (TUMS). He subsequently completed his urology residency at University of Nebraska Medical Center (UNMC) and urologic oncology fellowship training at UCLA’s Institute of Urologic Oncology (IUO), David Geffen School of Medicine. More >
Robert E. Reiter, MD
Director of the Institute of Urologic Oncology Prostate Cancer Program, Professor of Urology, Professor of Molecular Biology, Chief of the Division of Urologic Oncology, and co-Director of the Genitourinary Oncology Program in UCLA's Jonsson Cancer Center, Dr. Reiter attended Stanford Medical School, completed urologic training at Stanford and Baylor College of Medicine, completed additional fellowship training in urological cancer at the National Cancer Institute. More >
Christopher S. Saigal, MD
Professor and Vice Chair, Urology. Clinical practice, UCLA Westwood Campus. He is also on the staff of the West Los Angeles Veterans Affairs Medical Center. Dr. Saigal has had a longstanding clinical interest in urologic cancers and the surgical treatment of benign prostatic hyperplasia. His research is focused on patient-centered decision support and quality of care for urologic conditions. More >
Joseph D. Shirk, MD
Assistant Professor of Urology. Dr. Shirk earned his medical degree from the Medical College of Wisconsin. He completed his intern year at Boston Medical Center and subsequently completed his urology residency at the University of California, Los Angeles (UCLA), and urologic oncology fellowship training at UCLA’s Institute of Urologic Oncology (IUO), David Geffen School of Medicine. More >
Brian M. Shuch, MD
Director of the Institute of Urologic Oncology Kidney Cancer Program, Associate Professor of Urology, and Henry Alvin and Carrie L. Meinhardt Chair for Kidney Cancer Research, Dr. Shuch completed his urology training at UCLA followed by a 3-year Urologic Oncology Fellowship at the National Cancer Institute. More >